Newsletter Subject

4 Symbols On My Watchlist

From

biotechbreakouts.com

Email Address

kyle@biotechbreakouts.com

Sent On

Tue, Aug 4, 2020 11:51 PM

Email Preheader Text

Dear Undefined, Each Sunday I send out my watchlist to Trade With Kyle subscribers. It outlines: - W

Dear Undefined, Each Sunday I send out my watchlist to Trade With Kyle subscribers. It outlines: - Why I like the play - The time frame I expect to be in it for - The area I want to buy - Where I want to take profits - What price I’m stopping out at. For example, this week I’m eyeing ONTX, SBBP, EARS, AQST and a few others. Why do I like these symbols? A few reasons. First, I feel at their current price levels they offer an attractive risk vs. reward opportunity. You see, they all have upcoming catalysts, which I believe will keep prices up until the outcome of the catalyst is known. Now, if this isn’t clear, allow me to share an example. A few weeks ago I had my eyes on Dynavax (DVAX). Here’s what I wrote to Trade With Kyle subscribers about it: Catalyst Dates: Covid data due August Buy Zone: $8.30 to $9.00 Profit Zone: $9.50 or higher Stop Zone: $7.70 or below Now, I wouldn’t consider myself an expert at reading charts. But by the looks of it, the $8 level was holding… So I knew any entry close to that would allow me to have a tighter stop and offer the highest reward to risk trade. My thinking is traders will bid up the shares in hopes the news comes out positive. As they’re driving up the price of the stock… ...I’m peeling it off for profits. However, sometimes, you can get “lucky” too. What do I mean by that? The company you’re long, pre-releases positive news. Believe it or not… it happens a lot more times than I can remember. Good morning, News on DVAX! [image]( This isn't the Covid-19 news I'm looking for (which is coming in August), so I'm going to sell my shares here at $9.95 for a $4,500 win and look to rebuy. Listen, I’ve made over $10M in career trading profits*. One of the first strategies I ever mastered was the “catalyst run-up” strategy. While I haven’t crunched the official numbers, I wouldn’t be surprised if that strategy alone is reasonable for a few million in trading profits*. Anyways, I’m not bringing it up to brag. Not at all. You see, I’ve actually put together a training workshop which outlines “the catalyst run-up” strategy. [You can register for it right here.]( Like I said, I’ve probably made millions trading this strategy*. And despite how unusual and volatile 2020 has been… The strategy continued to work and make me money. [I can’t wait to show you how it works.]( [See you inside!]( Kyle Dennis *Results presented are not typical and may vary from person to person. Please see our full disclaimer here: ragingbull.com/disclaimer WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. [Special]( RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 [Click Here to stop receiving emails from kyle@biotechbreakouts.com]( [Unsubscribe from all RagingBull emails]( DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website,application or other service ("Services"), please review our full disclaimer located at [(disclaimer. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT beconstrued as a securities-related offer or solicitation, or be relied upon as personalizedinvestment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securitiesregulatory authority, or any self-regulatory organization. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, Ragingbull.com, LLC, its owners, and itsemployees may purchase, sell, or hold long or short positions in securities of the companies mentioned inthis communication. If you have a current active subscription with Biotech Breakouts you will need to contact us here if you want to cancel your subscription. Opting out of emails does not remove you from your service at BiotechBreakouts.com.

Marketing emails from biotechbreakouts.com

View More
Sent On

31/07/2021

Sent On

31/07/2021

Sent On

17/07/2021

Sent On

09/07/2021

Sent On

08/07/2021

Sent On

08/07/2021

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.